BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33826877)

  • 21. Prospective validation study of the International Classification of Functioning, Disability and Health score in Crohn's disease and ulcerative colitis.
    Leong RW; Huang T; Ko Y; Jeon A; Chang J; Kohler F; Kariyawasam V
    J Crohns Colitis; 2014 Oct; 8(10):1237-45. PubMed ID: 24662396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life outcomes and economic burden of inflammatory bowel disease in Japan.
    Yamabe K; Liebert R; Flores N; Pashos CL
    Clinicoecon Outcomes Res; 2019; 11():221-232. PubMed ID: 30881067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.
    Burisch J; Vardi H; Schwartz D; Friger M; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Lakatos L; Lakatos PL; D'Incà R; Sartini A; Valpiani D; Giannotta M; Arebi N; Duricova D; Bortlik M; Chetcuti Zammit S; Ellul P; Pedersen N; Kjeldsen J; Midjord JMM; Nielsen KR; Winther Andersen K; Andersen V; Katsanos KH; Christodoulou DK; Domislovic V; Krznaric Z; Sebastian S; Oksanen P; Collin P; Barros L; Magro F; Salupere R; Kievit HAL; Goldis A; Kaimakliotis IP; Dahlerup JF; Eriksson C; Halfvarson J; Fernandez A; Hernandez V; Turcan S; Belousova E; Langholz E; Munkholm P; Odes S;
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):454-464. PubMed ID: 32061322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression in working adults: comparing the costs and health outcomes of working when ill.
    Cocker F; Nicholson JM; Graves N; Oldenburg B; Palmer AJ; Martin A; Scott J; Venn A; Sanderson K
    PLoS One; 2014; 9(9):e105430. PubMed ID: 25181469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of inflammatory bowel disease on caregivers: significant burden and loss of productivity.
    Zand A; Kim BJ; van Deen WK; Stokes Z; Platt A; O'Hara S; Khong H; Hommes DW
    BMC Health Serv Res; 2020 Jun; 20(1):556. PubMed ID: 32552803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smoking is Associated with Higher Disease-related Costs and Lower Health-related Quality of Life in Inflammatory Bowel Disease.
    Severs M; Mangen MJ; van der Valk ME; Fidder HH; Dijkstra G; van der Have M; van Bodegraven AA; de Jong DJ; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; van de Meeberg PC; Mahmmod N; Ponsioen CY; Vermeijden JR; van der Meulen-de Jong AE; Pierik M; Siersema PD; Oldenburg B;
    J Crohns Colitis; 2017 Mar; 11(3):342-352. PubMed ID: 27647859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between physician-based assessment of disease activity, quality of life, and costs of ulcerative colitis in Poland.
    Kawalec P; Stawowczyk E
    Prz Gastroenterol; 2018; 13(1):61-68. PubMed ID: 29657613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
    Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
    World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Systematic Review of Productivity in Economic Evaluations of Workplace Interventions: A Need for Reporting Criteria?
    Jones C; Verstappen SMM; Payne K
    Appl Health Econ Health Policy; 2019 Oct; 17(5):591-613. PubMed ID: 30937837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Systematic Review of the Economic and Health-Related Quality of Life Impact of Advanced Therapies Used to Treat Moderate-to-Severe Ulcerative Colitis.
    Cichewicz A; Tencer T; Gupte-Singh K; Egodage S; Burnett H; Kumar J
    Adv Ther; 2023 May; 40(5):2116-2146. PubMed ID: 37000363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland.
    Holko P; Kawalec P; Mossakowska M; Pilc A
    PLoS One; 2016; 11(12):e0168586. PubMed ID: 27992531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cost burden of Crohn's disease and ulcerative colitis depending on biologic treatment status - a Danish register-based study.
    Alulis S; Vadstrup K; Olsen J; Jørgensen TR; Qvist N; Munkholm P; Borsi A
    BMC Health Serv Res; 2021 Aug; 21(1):836. PubMed ID: 34407821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Productivity Losses Due to Migraine in Slovenia: An Analysis of Absenteeism and Presenteeism Costs Based on Administrative and Self-Reported Data.
    Lotrič Dolinar A; Žvan B; Došenović Bonča P
    Zdr Varst; 2020 Jun; 59(2):75-82. PubMed ID: 32952706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating the Effect and Economic Impact of Absenteeism, Presenteeism, and Work Environment-Related Problems on Reductions in Productivity from a Managerial Perspective.
    Strömberg C; Aboagye E; Hagberg J; Bergström G; Lohela-Karlsson M
    Value Health; 2017 Sep; 20(8):1058-1064. PubMed ID: 28964437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study.
    Busingye D; Pollack A; Chidwick K
    PLoS One; 2021; 16(5):e0252458. PubMed ID: 34043730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costs of ulcerative colitis from a societal perspective in a regional health care area in Spain: A database study.
    Aldeguer X; Sicras-Mainar A
    Gastroenterol Hepatol; 2016 Jan; 39(1):9-19. PubMed ID: 26211705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study.
    Yu Q; Zhu C; Feng S; Xu L; Hu S; Chen H; Chen H; Yao S; Wang X; Chen Y
    J Med Internet Res; 2021 Jan; 23(1):e20629. PubMed ID: 33399540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost Burden of Crohn's Disease and Ulcerative Colitis in the 10-Year Period Before Diagnosis-A Danish Register-Based Study From 2003-2015.
    Vadstrup K; Alulis S; Borsi A; Gustafsson N; Nielsen A; Wennerström ECM; Jørgensen TR; Qvist N; Munkholm P
    Inflamm Bowel Dis; 2020 Aug; 26(9):1377-1382. PubMed ID: 31693731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.